📰 Registration Document News
Page 46 - Registration Document News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Registration Document. Real-time updates on events, politics, business and more.
July 5, 2023
2022 Universal Registration Document including the annual financial report Definitions ...
July 4, 2023
Regulated information Description of the share buyback program authorized by the Combined Shareholders’ Meeting ofBureau Veritas SA of June 22, 2023 Pursuant to Articles 241-1...
July 3, 2023
Issy-les-Moulineaux, July 3, 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY IN ANY JURISDICTION OR TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION WHERE IT IS...
July 3, 2023
COFACE SA: Half-year statement of the liquidity agreement of COFACE SA with ODDO BHF Paris, 3rd July 2023 – 17.45 Pursuant to Regulation No 596/2014 of 16 April 2014 on market abuse1 As per...
June 30, 2023
>> cnn has exclusively obtained documents that suggests a top russian general, sergey surovikin, who has not been seen in public since last saturday short-lived or vault was a secret vip member of the mercenary wagner group that led the rebellion. cnns matthew chance joins us now from moscow for more on the man nicknamed general armageddon through his ruthless tactics. matthew, these documents, what do they tell us about general surovikin? >> they are pretty interesting. because they suggest or ...
June 30, 2023
Issy-les-Moulineaux, June 30, 2023 Sodexo (NYSE Euronext Paris FR 0000121220-OTC: SDXAY) On-site Services revenue growth as expected Ongoing acceleration in
June 30, 2023
Trial met primary endpoint with a statistically significant higher percentage of patients achieving a clinically meaningful cholestasis response compared to placebo Elafibranor was well tolerated with a safety profile consistent with previous studies Resu...
June 30, 2023
Trial met primary endpoint with a statistically significant higher percentage of patients achieving a clinically meaningful cholestasis response compared to placeboElafibranor was well tolerated with a safety profile
June 30, 2023
Press Release Poxel Announces the Approval of a Prospectus for the Listing of New Shares on Euronext Paris LYON,...